The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.
Background. Molecular syndromic diagnostic panels can enhance pathogen identification in the approximately 2–4 billion episodes of acute gastroenteritis that occur annually worldwide. However, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results